Jay R. Luly - Net Worth and Insider Trading
Jay R. Luly Net Worth
The estimated net worth of Jay R. Luly is at least $9 Million dollars as of 2024-11-13. Jay R. Luly is the President and CEO of Enanta Pharmaceuticals Inc and owns about 806,793 shares of Enanta Pharmaceuticals Inc (ENTA) stock worth over $9 Million. Details can be seen in Jay R. Luly's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jay R. Luly has not made any transactions after 2023-12-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Jay R. Luly
Jay R. Luly Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jay R. Luly owns 1 companies in total, including Enanta Pharmaceuticals Inc (ENTA) .
Click here to see the complete history of Jay R. Luly’s form 4 insider trades.
Insider Ownership Summary of Jay R. Luly
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ENTA | Enanta Pharmaceuticals Inc | 2023-12-05 | director & President and CEO |
Jay R. Luly Latest Holdings Summary
Jay R. Luly currently owns a total of 1 stock. Jay R. Luly owns 806,793 shares of Enanta Pharmaceuticals Inc (ENTA) as of December 5, 2023, with a value of $9 Million.
Latest Holdings of Jay R. Luly
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ENTA | Enanta Pharmaceuticals Inc | 2023-12-05 | 806,793 | 10.66 | 8,600,413 |
Holding Weightings of Jay R. Luly
Jay R. Luly Form 4 Trading Tracker
According to the SEC Form 4 filings, Jay R. Luly has made a total of 4 transactions in Enanta Pharmaceuticals Inc (ENTA) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Enanta Pharmaceuticals Inc is the sale of 7,230 shares on December 5, 2023, which brought Jay R. Luly around $69,625.
Insider Trading History of Jay R. Luly
- 1
Jay R. Luly Trading Performance
Jay R. Luly Ownership Network
Ownership Network List of Jay R. Luly
Ownership Network Relation of Jay R. Luly
Jay R. Luly Owned Company Details
What does Enanta Pharmaceuticals Inc do?
Who are the key executives at Enanta Pharmaceuticals Inc?
Jay R. Luly is the director & President and CEO of Enanta Pharmaceuticals Inc. Other key executives at Enanta Pharmaceuticals Inc include Chief Medical Officer Scott T. Rottinghaus , Sr. VP & New Product Dev. Tara Lynn Kieffer , and Sr. VP & Business Dev. Brendan Luu .
Enanta Pharmaceuticals Inc (ENTA) Insider Trades Summary
Over the past 18 months, Jay R. Luly made 1 insider transaction in Enanta Pharmaceuticals Inc (ENTA) with a net sale of 7,230. Other recent insider transactions involving Enanta Pharmaceuticals Inc (ENTA) include a net sale of 12,479 shares made by Scott T. Rottinghaus , a net sale of 9,391 shares made by Tara Lynn Kieffer , and a net sale of 15,295 shares made by Terry Vance .
In summary, during the past 3 months, insiders sold 0 shares of Enanta Pharmaceuticals Inc (ENTA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 53,756 shares of Enanta Pharmaceuticals Inc (ENTA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 53,756 shares.
Enanta Pharmaceuticals Inc (ENTA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Enanta Pharmaceuticals Inc Insider Transactions
Jay R. Luly Mailing Address
Above is the net worth, insider trading, and ownership report for Jay R. Luly. You might contact Jay R. Luly via mailing address: C/o Enanta Pharmaceuticals, Inc., 500 Arsenal Street, Watertown Ma 02472.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
